1. Home
  2. UPWK vs COLL Comparison

UPWK vs COLL Comparison

Compare UPWK & COLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Upwork Inc.

UPWK

Upwork Inc.

HOLD

Current Price

$11.11

Market Cap

1.4B

Sector

Technology

ML Signal

HOLD

Logo Collegium Pharmaceutical Inc.

COLL

Collegium Pharmaceutical Inc.

HOLD

Current Price

$33.53

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UPWK
COLL
Founded
1998
2002
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.2B
IPO Year
2018
2015

Fundamental Metrics

Financial Performance
Metric
UPWK
COLL
Price
$11.11
$33.53
Analyst Decision
Buy
Strong Buy
Analyst Count
12
5
Target Price
$22.73
$51.40
AVG Volume (30 Days)
2.9M
496.0K
Earning Date
05-04-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.84
1.73
Revenue
$787,784,000.00
$780,567,000.00
Revenue This Year
$9.10
$8.01
Revenue Next Year
$13.60
N/A
P/E Ratio
$13.05
$18.94
Revenue Growth
2.40
23.62
52 Week Low
$10.52
$23.23
52 Week High
$22.84
$50.79

Technical Indicators

Market Signals
Indicator
UPWK
COLL
Relative Strength Index (RSI) 38.30 37.32
Support Level $10.52 $31.01
Resistance Level $13.97 $36.20
Average True Range (ATR) 0.50 1.22
MACD 0.16 0.31
Stochastic Oscillator 36.62 35.08

Price Performance

Historical Comparison
UPWK
COLL

About UPWK Upwork Inc.

Upwork Inc is a United States-based company that operates an online marketplace that enables businesses to find and work with skilled independent professionals. The company develops platform for hiring and freelancing purposes and connects businesses with AI-enabled talent across every on-demand work type, including freelance, agency, fractional, and payrolled. The business generates revenue from Talent and Clients across the USA, India, Pakistan, the Philippines and the rest of the world. Maximum revenue of the company is derived from Talent segment.

About COLL Collegium Pharmaceutical Inc.

Collegium Pharmaceutical Inc is a diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions. The company has developed, licensed, and acquired a portfolio of meaningfully differentiated products for the treatment of attention deficit hyperactivity disorder (ADHD) and moderate to severe pain. It commercializes its products in the United States, including Jornay PM, Belbuca, Xtampza ER, Nucynta ER, Nucynta IR (collectively, the Nucynta Products), and Symproic. The company's product portfolio includes Jornay PM, Belbuca, Xtampza ER, Nucynta IR, Nucynta ER, and Symproic.

Share on Social Networks: